An Innovative Approach to Manufacturing Biologics Using Microbial Fermentation

Brought to you by BioVectra

Please complete the form to download the whitepaper.

*

Does your company outsource CDMO services for the production of large molecules by microbial fermentation? Please select all that apply. * Yes - e. Coli Yes â€“ Pichia Pastoris Yes â€“ Saccharomyces Cerevisiae No

What services does your company require when you outsource? Please select all that apply. *
Cell line development Cell banking Process Development Analytical Development GMP manufacturing up to 500 L GMP manufacturing 500 L and above Miscellaneous Services By completing and submitting this form, you understand and agree that use of American Chemical Society (ACS) websites are subject to the ACS Terms of Use and ACS Privacy Policy , including the fact that ACS and its third party sponsors can contact you based on the information provided. In order to process your registration completely, you understand that your information will be transferred to ACSâ€™ affiliates globally.

Overview

The use of microbial fermentation to make biologics is growing rapidly. A manufacturing platform is an increasingly popular way to speed up process development stages and get a biologic to market faster. High-throughput systems can speed up optimization of each of these platform steps. Single-use, disposable technologies are starting to replace stainless steel to streamline biologic manufacturing, reduce costs, minimize contamination risks and allow rapid expansion of capacity.

Key Learning Objectives

What a platform technology is and how it can speed up process development.
How high-throughput technologies can be used in biologic process development.
What single-use, disposable technologies are currently on the market for biologic manufacturing and the advantages of using them.